<DOC>
	<DOC>NCT00174486</DOC>
	<brief_summary>Assessment of duration of action, safety &amp; toleration of different formulations and doses of UK-369,003 and Cialis in patients with male erectile dysfunction. Patients should have previously been on PDE5 inhibitors and have been respondents to the drug. Duration of treatment is 4 weeks.</brief_summary>
	<brief_title>Assessment Of Duration Of Action, Safety &amp; Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Erectile Dysfunction Alpha blockers and Nitrates of any preparation</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>